Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015 The issued patent provides intellectual property protection for ERAS-0015 and related compositions until at least 2043 Initial Phase 1 monotherapy data for ERAS-0015 and pan-KRAS inhibitor ERAS-4001 expected in 2026 SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that the U.S. Patent and Tra...
A director at First Horizon Corp sold 155,149 shares at 21.312USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Epsilon Announces Third Quarter 2025 Results HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported third quarter 2025 financial and operating results. Third Quarter 2025 Highlights: Epsilon - Q3 2025 Q3 2025Q2 2025Q3 2024QoQ%YoY%YTD 2025NRI Production GasMMcf2,1362,7521,304-22%64%7,628OilMbbl394453-11%-26%129NGLMbbl1481778%-18%38TotalMmcfe2,4563,0641,727-20%42%8,629DailyMmcfe/d26.733.718.8 31.6 Revenues$M Gas 4,7586,9101,904-31%150%22,282Oil 2,5112,7253,965-8%-37%8,505NGL 26714533584%-20%799Mid...
Erasca to Present at Upcoming Conferences in November SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in November 2025 and will also participate in one-on-one investor meetings at each of these conferences. Guggenheim 2nd Annual Healthcare Innovation Conference (November 10-12, 2025)Location: Boston, MA Form...
Genie Energy Announces Third Quarter 2025 Results Newark, NJ , Nov. 03, 2025 (GLOBE NEWSWIRE) -- : Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the third quarter of 2025. Michael Stein, Chief Executive Officer of Genie Energy, commented: "Genie Energy achieved another quarter of double-digit topline growth to attain record third quarter revenue. The revenue increase was fueled by an increase in per meter electricity consumption, rising commodity prices, and RCE base growth at Genie Retail Energy (GRE). How...
Epsilon Energy Ltd. Schedules Third Quarter 2025 Earnings Release and Conference Call HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that it will issue its third quarter 2025 earnings release on Wednesday, November 5, 2025 after the market close and host a conference call to discuss its financial and operating results on Thursday, November 6, 2025 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time). Interested parties in the United States and Canada may participate toll-free by dialing (833) 816-1385. Internatio...
Genie Energy to Report Third Quarter 2025 Results NEWARK, NJ, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Genie Energy Ltd., (NYSE: GNE), a leading retail energy and renewable energy solutions provider, will announce financial and operational results for the third quarter of 2025 on Monday, November 3, 2025. Genie Energy will issue an earnings release over a wire service and post it in the “Investors” section of the Genie Energy website () at 7:30 AM Eastern. The release also will be filed in a current report (Form 8-K) with the SEC. At 8:30 AM Eastern, Genie Energy’s management will host a confe...
Epsilon Announces New and Revised Senior Secured Reserve-Based Revolving Credit Facility HOUSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported the closing of a new and revised senior secured reserve-based revolving credit facility (the “Credit Facility”) with Frost Bank as the administrative agent and Frost Bank and Texas Capital Bank as lenders. The new Credit Facility replaces the Company’s previous credit facility. Term highlights of the Credit Facility: Epsilon Energy USA Inc. and Epsilon Energy Ltd. as co-borrowers...
Epsilon Energy Ltd. Announces Quarterly Dividend HOUSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that its Board of Directors has declared a dividend of $0.0625 per share of common stock (annualized $0.25/sh) to the stock holders of record at the close of business on September 15, 2025, payable on September 30, 2025. All dividends paid by the Company are “eligible dividends” as defined in subsection 89(1) of the Income Tax Act (Canada), unless indicated otherwise. About Epsilon Epsilon Energy Ltd. is a North Amer...
Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference being held at the Sheraton New York Times Square in New York, NY. Management will present on Tuesday, September 9, 2025, at 3:20 pm Eastern Time and will also participate...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.